Table 5 –
Association of clinical factors with overall survival in the preoperative renal cell carcinoma population (n = 175) a
Factor | N [n deaths] | Univariate |
Multivariate |
||
---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | ||
Age | 175 | 1.23 (0.76–1.98) | 0.391 | ||
Tumor size | 175 | 2.53 (1.77–3.62) | <0.001 | 1.13 (0.56–2.29) | 0.723 |
Tumor grade | |||||
Grade 2 or low | 50 [2] | 1 | |||
Grade >2 or high | 90 [14] | 8.42 (1.11–6.41) | 0.039 | ||
Not available | 35 | ||||
TNM stage | |||||
I or II | 101 [3] | 1 | |||
III or IV | 74 [16] | 11.67 (2.68–5.08) | 0.001 | ||
Nephrectomy type | |||||
Partial | 113 [2] | 1 | |||
Radical | 62 [17] | 34.8 (4.6–261.6) | <0.001 | ||
Surgical margins | |||||
Negative | 170 [16] | 1 | |||
Positive | 5 [3] | 5.18 (2.12–12.6) | <0.001 | 4.06 (0.75–22) | 0.105 |
SSIGN score | 118 | 3.37 (2.21–5.13) | <0.001 | 5.04 (2.53–10) | <0.001 |
New GAG score | 175 | 1.25 (0.97–1.62) | 0.080 | ||
6s CS | 175 | 0.35 (0.14–0.91) | 0.032 | ||
6s/(4s + 6s) CS | 175 | 0.62 (0.34–1.14) | 0.125 | ||
CStot | 175 | 1.34 (1.11–1.62) | 0.002 | 1.51 (1.19–1.93) | <0.001 |
CS charge | 175 | 0.44 (0.24–0.80) | 0.008 | ||
175 | 0.80 (0.52–1.22) | 0.293 |
HR = hazard ratio; CI = confidence interval; GAG = glycosaminoglycan; SSIGN = Stage, Size, Grade, and Necrosis; CS = chondroitin sulfate; HS = heparan sulfate.
In multivariate analysis, patients with missing data for any of the selected covariates were omitted (n = 57). Continuous variables were centered to the mean and scaled to the standard deviation.